Wenting Liao

1.5k total citations · 1 hit paper
9 papers, 851 citations indexed

About

Wenting Liao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Wenting Liao has authored 9 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Wenting Liao's work include MicroRNA in disease regulation (3 papers), Cancer Cells and Metastasis (3 papers) and Peptidase Inhibition and Analysis (2 papers). Wenting Liao is often cited by papers focused on MicroRNA in disease regulation (3 papers), Cancer Cells and Metastasis (3 papers) and Peptidase Inhibition and Analysis (2 papers). Wenting Liao collaborates with scholars based in China and United States. Wenting Liao's co-authors include Yanqing Ding, Liang Li, Xiao-Liang Lan, Yingke Liang, Wei Wang, Yuhui Yan, Fuyao Song, Xiaoxia Zhu, Zhao‐Chong Zeng and Fangfang Wang and has published in prestigious journals such as Genes & Development, Molecular Cancer and Oncotarget.

In The Last Decade

Wenting Liao

9 papers receiving 844 citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer

2019 588 citations Wei Wang, Xiao-Liang Lan et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wenting Liao China	7	662	461	305	104	84	9	851
Anna Sanchez Calle Japan	12	712 1.1×	546 1.2×	282 0.9×	51 0.5×	54 0.6×	15	909
Yanzi Gu China	8	669 1.0×	486 1.1×	180 0.6×	246 2.4×	93 1.1×	13	876
Aleksandra Markiewicz Poland	15	287 0.4×	283 0.6×	499 1.6×	90 0.9×	124 1.5×	33	714
George Koutsodontis Greece	12	356 0.5×	201 0.4×	402 1.3×	70 0.7×	74 0.9×	20	674
Enhao Zhao China	16	412 0.6×	335 0.7×	162 0.5×	196 1.9×	101 1.2×	25	715
Saswati Karmakar United States	12	467 0.7×	165 0.4×	301 1.0×	127 1.2×	86 1.0×	20	692
Gokce Oguz Singapore	7	351 0.5×	183 0.4×	242 0.8×	122 1.2×	55 0.7×	12	558
Sylvia Mahara Singapore	8	502 0.8×	179 0.4×	210 0.7×	80 0.8×	47 0.6×	9	658

Countries citing papers authored by Wenting Liao

Since Specialization

Citations

This map shows the geographic impact of Wenting Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenting Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenting Liao more than expected).

Fields of papers citing papers by Wenting Liao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenting Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenting Liao. The network helps show where Wenting Liao may publish in the future.

Co-authorship network of co-authors of Wenting Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Wenting Liao. A scholar is included among the top collaborators of Wenting Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenting Liao. Wenting Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Yang, Jie, Qiao-Li Wang, Guannan Wang, et al.. (2024). A pan-KRAS degrader for the treatment of KRAS-mutant cancers. Cell Discovery. 10(1). 70–70. 8 indexed citations

2.

Liao, Wenting, Michael J. Overman, Adam T. Boutin, et al.. (2020). Abstract B52: KRAS-IRF2 axis drives immune suppression and immune therapy resistance in colorectal cancer. Molecular Cancer Research. 18(5_Supplement). B52–B52. 1 indexed citations

3.

Wang, Wei, Xiao-Liang Lan, Zhao‐Chong Zeng, et al.. (2019). CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer. Molecular Cancer. 18(1). 91–91. 588 indexed citations breakdown →

4.

Hou, Pingping, Xingdi Ma, Qiang Zhang, et al.. (2019). USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation. Genes & Development. 33(19-20). 1361–1366. 69 indexed citations

5.

Li, Yuling, Zhenbing Lv, Guoyang He, et al.. (2015). The SOX17/miR-371-5p/SOX2 axis inhibits EMT, stem cell properties and metastasis in colorectal cancer. Oncotarget. 6(11). 9099–9112. 50 indexed citations

6.

Lu, Gui-Feng, Yaling Sun, Shengli An, et al.. (2015). MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer. Experimental and Molecular Pathology. 99(1). 173–179. 38 indexed citations

7.

Liao, Wenting, Yaping Ye, Yong‐Jian Deng, Xiu‐Wu Bian, & Yan-qing Ding. (2014). Metastatic cancer stem cells: from the concept to therapeutics.. PubMed. 3(2). 46–62. 69 indexed citations

8.

Liao, Wenting. (2012). Expression of SATB1 and its clinicopathologic significance in colorectal cancer. 1 indexed citations

9.

Li, Jie, Li Yin, Xintao Zhang, et al.. (2012). Co-expression of CXCR4 and CD133 proteins is associated with poor prognosis in stage II–III colon cancer patients. Experimental and Therapeutic Medicine. 3(6). 973–982. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Sanchez Calle Breakdown of academic impact, for papers by Yanzi Gu Breakdown of academic impact, for papers by Aleksandra Markiewicz Breakdown of academic impact, for papers by George Koutsodontis Breakdown of academic impact, for papers by Enhao Zhao Breakdown of academic impact, for papers by Saswati Karmakar Breakdown of academic impact, for papers by Gokce Oguz Breakdown of academic impact, for papers by Sylvia Mahara